Structural characterization of a L-dehydroascorbic acid-L-homocysteine thiolactone reaction product: Intracellular

Ghizlane Loubane1, Gabriel Robert2, Syed Benazir Firdaus1

  • 1Département de Pharmacologie et Physiologie Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, 3001 12 Ave N, Sherbrooke, Quebec J1H5N4, Canada.

Insights

Homocysteine thiolactone (HTL) can cause protein aggregation. Dehydroascorbate (DHA), derived from ascorbate, reacts with L-HTL to form a product that prevents protein N-homocysteinylation, potentially protecting against neurodegenerative diseases.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Oxidative Stress Research

Background:

  • Homocysteine thiolactone (HTL) is linked to cardiovascular and neurological diseases due to its ability to bind protein lysine residues, potentially causing aggregation.
  • Ascorbate (Vitamin C) combats oxidative stress and can be oxidized to dehydroascorbate (DHA), which can be reduced by thiols.
  • Understanding HTL's interactions and potential protective mechanisms is crucial for disease prevention.

Purpose of the Study:

  • To investigate the reaction products of L-HTL with aldehydes and DHA.
  • To elucidate the structural characteristics of these reaction products using advanced analytical techniques.
  • To assess the protective potential of the DHA-L-HTL reaction product against protein N-homocysteinylation and aggregation.

Main Methods:

  • Purification and structural determination of reaction products using 1D and 2D-nuclear magnetic resonance (NMR).
  • High-resolution accurate electrospray ionization tandem mass spectrometry (ESIMS/MS) for structural confirmation.
  • In vitro assays to assess the inhibition of N-homocysteinylation of cytochrome c.
  • Cell-based studies using human neuroblastoma cells (SH-SY5Y).

Main Results:

  • Novel reaction products were identified from L-HTL with formaldehyde, propionaldehyde, and DHA.
  • The DHA-L-HTL adduct features a six-member thiazinane ring with a carboxylic acid group.
  • Formation of the DHA-L-HTL reaction product inhibited N-homocysteinylation of cytochrome c by L-HTL.
  • The DHA-L-HTL adduct was observed in SH-SY5Y cells exposed to L-HTL and DHA/ascorbate, suggesting in vivo formation.

Conclusions:

  • The reaction between DHA and L-HTL yields a stable adduct that prevents protein N-homocysteinylation.
  • DHA, through its reaction with L-HTL, shows potential as a protective agent against HTL-induced protein aggregation and associated pathologies.
  • These findings highlight a novel protective role for ascorbate/DHA in mitigating the detrimental effects of homocysteine thiolactone.